ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,57
0,91%
Dow Jones
38 778,10
0,49%
DAX
18 068,21
0,26%
Brent Oil
83,90
2,16%
Bitcoin
66 516,21
-0,18%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pyxis Oncology Inc (PYXS)

  7. Pyxis Oncology Inc (PYXS) Actualités

PYXS

Pyxis Oncology (PYXS)

Pyxis Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PYXS
DateHeureSourceTitreSymboleSociété
12/06/202422h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
10/06/202413h30GlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerNASDAQ:PYXSPyxis Oncology Inc
07/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
30/05/202413h30GlobeNewswire Inc.Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
14/05/202414h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
14/05/202413h30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
09/05/202413h30GlobeNewswire Inc.Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
28/03/202421h30GlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
27/03/202412h30GlobeNewswire Inc.Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty RightsNASDAQ:PYXSPyxis Oncology Inc
21/03/202412h30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023NASDAQ:PYXSPyxis Oncology Inc
13/03/202413h00GlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFANASDAQ:PYXSPyxis Oncology Inc
08/03/202422h03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYXSPyxis Oncology Inc
07/03/202422h30GlobeNewswire Inc.Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024NASDAQ:PYXSPyxis Oncology Inc
05/03/202422h45GlobeNewswire Inc.Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual MeetingNASDAQ:PYXSPyxis Oncology Inc
27/02/202414h00GlobeNewswire Inc.Pyxis Oncology Announces $50 Million Private PlacementNASDAQ:PYXSPyxis Oncology Inc
06/12/202322h50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
28/11/202313h00GlobeNewswire Inc.Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical OfficerNASDAQ:PYXSPyxis Oncology Inc
07/11/202322h30GlobeNewswire Inc.Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate UpdateNASDAQ:PYXSPyxis Oncology Inc
27/10/202322h34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PYXSPyxis Oncology Inc
27/09/202315h18GlobeNewswire Inc.Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023NASDAQ:PYXSPyxis Oncology Inc
05/09/202323h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PYXSPyxis Oncology Inc
31/08/202322h01GlobeNewswire Inc.Pyxis Oncology to Participate in Two Upcoming Investment ConferencesNASDAQ:PYXSPyxis Oncology Inc
25/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PYXSPyxis Oncology Inc
23/08/202323h30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PYXSPyxis Oncology Inc
23/08/202323h28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PYXSPyxis Oncology Inc
23/08/202323h28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYXSPyxis Oncology Inc
23/08/202314h35GlobeNewswire Inc.Pyxis Oncology Successfully Completes Acquisition of ApexigenNASDAQ:PYXSPyxis Oncology Inc
11/08/202313h26Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PYXSPyxis Oncology Inc
11/08/202313h00GlobeNewswire Inc.Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate UpdateNASDAQ:PYXSPyxis Oncology Inc
01/08/202322h01GlobeNewswire Inc.Pyxis Oncology to Present at BTIG Virtual Biotechnology ConferenceNASDAQ:PYXSPyxis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:PYXS

Dernières Valeurs Consultées

BOV
BCFF11
Fundo Invest Imobiliario...
CSE
BRCO
Buscando Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés